1. Home
  2. LSTA vs WVVI Comparison

LSTA vs WVVI Comparison

Compare LSTA & WVVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LSTA
  • WVVI
  • Stock Information
  • Founded
  • LSTA 1980
  • WVVI 1983
  • Country
  • LSTA United States
  • WVVI United States
  • Employees
  • LSTA N/A
  • WVVI N/A
  • Industry
  • LSTA Misc Health and Biotechnology Services
  • WVVI Beverages (Production/Distribution)
  • Sector
  • LSTA Health Care
  • WVVI Consumer Staples
  • Exchange
  • LSTA Nasdaq
  • WVVI Nasdaq
  • Market Cap
  • LSTA 20.9M
  • WVVI 20.4M
  • IPO Year
  • LSTA N/A
  • WVVI N/A
  • Fundamental
  • Price
  • LSTA $2.44
  • WVVI $3.75
  • Analyst Decision
  • LSTA Strong Buy
  • WVVI
  • Analyst Count
  • LSTA 2
  • WVVI 0
  • Target Price
  • LSTA $23.50
  • WVVI N/A
  • AVG Volume (30 Days)
  • LSTA 43.5K
  • WVVI 11.2K
  • Earning Date
  • LSTA 11-11-2025
  • WVVI 11-11-2025
  • Dividend Yield
  • LSTA N/A
  • WVVI N/A
  • EPS Growth
  • LSTA N/A
  • WVVI N/A
  • EPS
  • LSTA N/A
  • WVVI N/A
  • Revenue
  • LSTA $1,070,000.00
  • WVVI $38,384,350.00
  • Revenue This Year
  • LSTA N/A
  • WVVI N/A
  • Revenue Next Year
  • LSTA N/A
  • WVVI N/A
  • P/E Ratio
  • LSTA N/A
  • WVVI N/A
  • Revenue Growth
  • LSTA N/A
  • WVVI N/A
  • 52 Week Low
  • LSTA $1.87
  • WVVI $3.17
  • 52 Week High
  • LSTA $4.20
  • WVVI $7.18
  • Technical
  • Relative Strength Index (RSI)
  • LSTA 49.36
  • WVVI 48.24
  • Support Level
  • LSTA $2.35
  • WVVI $3.46
  • Resistance Level
  • LSTA $2.61
  • WVVI $3.74
  • Average True Range (ATR)
  • LSTA 0.16
  • WVVI 0.24
  • MACD
  • LSTA -0.00
  • WVVI 0.05
  • Stochastic Oscillator
  • LSTA 35.71
  • WVVI 86.54

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The group has one operating segment, the research and development of its investigational drug product.

About WVVI Willamette Valley Vineyards Inc.

Willamette Valley Vineyards Inc produces and sells premium, super-premium, and ultra-premium wines. The grapes are harvested, fermented, and made into wine at the company's Turner winery, and the wines are sold principally under its Willamette Valley Vineyards label and also under the Griffin Creek, Tualatin Estate, Pambrun, Maison Bleue, Natoma, Metis, and Elton labels. It operates under two operating segments, direct sales and distributor sales. Direct sales include retail sales in its tasting room and remote sites, wine club sales, online sales, on-site events, kitchen and catering sales, and other sales made directly to the consumer without the use of an intermediary. Distributor sales include all sales through a third party where prices are given at a wholesale rate.

Share on Social Networks: